-
Relieve the patient's cardiac symptoms within two weeks Jixing Pharmaceutical owns R&D rights in Greater China
Time of Update: 2021-08-02
On July 19, 2021, Cytokinetics announced that in patients with obstructive hypertrophic cardiomyopathy (oHCM), its new drug CK-274 has achieved positive top lines in both dose cohorts of phase 2 clinical trials.
-
Tianjin Boai Biopharmaceuticals fined 3.01 million yuan for producing counterfeit drugs, legal representative was banned for life
Time of Update: 2021-08-02
5 yuan of illegal income; order the suspension of production and business for rectification; and Impose a fine of 30 times the value of illegally produced drugs (91591.
-
Jiangsu Provincial Health Commission: Strictly control the unreasonable increase in medical expenses
Time of Update: 2021-08-01
Standardize medical behavior Standardize medical behavior The “Notice” emphasizes that medical institutions and medical personnel of all types and levels shall conduct diagnosis and treatment activities in accordance with the approved diagnosis and treatment subjects, scope of practice, etc.
-
Roche and FDA start negotiations on Alzheimer's disease drug candidate Gantenerumab
Time of Update: 2021-07-31
Among trial participants with dominant inherited Alzheimer's disease (DIAD), treatment with Roche Gantenerumab can reduce the biomarkers of disease and neurodegenerative diseases in the brain, which can cause early-onset memory loss and Other symptoms .
-
Health Commission: 30 new confirmed cases on the 16th, 2 local
Time of Update: 2021-07-31
Health Commission: 30 new confirmed cases on the 16th, 2 local Health Commission: 30 new confirmed cases on the 16th, 2 local cases Health Commission: 30 new confirmed cases on the
-
Fluid equipment-the first phase of the 9th Shanghai Biological Fermentation Exhibition in 2021
Time of Update: 2021-07-31
The 9th Shanghai Biological Fermentation Exhibition in 2021 - Fluid Equipment Zone has gathered 150 industry brand enterprises, bringing new products, new technologies and new processes to the industry .
-
Medical insurance reform continues to enter the deep water area, with the health of the whole people supporting a comprehensive well-off
Time of Update: 2021-07-31
From free treatment of patients with new coronary pneumonia to free vaccination, from normalized procurement of medicines and high-value consumables to the realization of direct settlement of outpatient expenses across provinces, China's medical insurance reform is continuously moving into the deep water area, focusing on solving the "difficult to see a doctor".
-
An increase of nearly 200% in five years!
Time of Update: 2021-07-31
Continued rapid growth According to Meinenet data, in 2020, the total amount of drugs used in public hospitals in key provinces and cities in China has exceeded 200 billion yuan, and the digestion, metabolism and anti-diabetic drug market accounted for 14.
-
The State Drug Administration issued an announcement on the implementation of the "Regulations on the Supervision and Administration of Medical Devices" and other matters
Time of Update: 2021-07-31
2. Regarding medical device registration and filing management Starting from June 1, 2021, before the relevant provisions of the new "Regulations" supporting registration and filing are issued and implemented, medical device registration applicants and filing persons will continue to apply for registration and filing in accordance with the current regulations .
-
WHO says the epidemic may not be fully controlled this year
Time of Update: 2021-07-31
Comprehensive news: The latest data from the official website of the World Health Organization shows that as of 17:42 on the 19th Central European Time, there are a total of 190,597,409 confirmed cases of new crowns worldwide, and a total of 4093145 deaths .
-
Another first imitation of Dongyang Sunshine, "Entacapone" is about to be approved
Time of Update: 2021-07-31
This time, Dongyang Sunshine's entacapone generic drug's listing application has entered the administrative examination and approval stage first, and it is expected to become the first imitation of this product in China .
-
Artificial intelligence helps people with aphasia and paralysis re-open their mouths
Time of Update: 2021-07-31
According to the " New York Times " report, when this man named "Pancho" is thinking about words, the brain's communication center will be activated, and the electrodes will detect these signals .
-
What are the characteristics of lambda mutant strains spreading in 29 countries?
Time of Update: 2021-07-31
According to a report by Peninsula Chinese website, the mutated new coronavirus "Lambda", which was first discovered in Peru, has appeared in 29 countries .
-
Nanjing: Retail pharmacies in the city suspend sales of medicines such as fever and cough
Time of Update: 2021-07-31
The announcement clearly stated that in addition to emergency and fever clinics, hospitals at level 2 and above have fully implemented appointment registration, strictly restricted visits and escorts, and retail pharmacies in the city have suspended sales (including online sales) to the public, such as fever, cough, antiviral and antibiotics, etc.
-
How is vaccination for adolescents different from that for adults?
Time of Update: 2021-07-31
Wang Guiqiang, member of the State Council’s Scientific Research Expert Group on the Joint Prevention and Control Mechanism of New Coronary Pneumonia: The vaccines for adults and children and adolescents are all inactivated vaccines, and their dosages and dosage forms are the same.
-
The first domestic animal heart warm blood transfer was successful
Time of Update: 2021-07-31
In this medical experiment, Professor Li Ping from the Department of Cardiovascular Surgery of Wuhan Union Medical College Hospital and the team of engineers from Xinqing Medical, jointly arrested the heart of the medical sheep at the Taizhou Animal Center in order to connect with the warm blood transfer equipment and successfully passed the autologous Blood perfusion realizes extracorporeal rebound .
-
National Medical Insurance Administration: Several measures are being formulated to accelerate the implementation of the "Internet +" medical insurance payment policy
Time of Update: 2021-07-31
A few days ago, the National Medical Insurance Bureau emphasized in its response to Recommendation No. 6235 of the Fourth Session of the 13th National People’s Congress that it is formulating a "Int
-
Rapid whole-genome sequencing improves early diagnosis of rare diseases in children
Time of Update: 2021-07-31
Children's Hospital of Fudan University vice president Professor ZHOU Wen-hao said that the consensus of experts compiled a collection of the joint efforts of many domestic medical institutions and experts, for the clinical practice rapid whole genome sequencing of genetic diseases critically ill neonates China made complete Summary .
-
The second domestic company, Chenxin Pharmaceutical's Teriflunomide Generic Drug Application for Production
Time of Update: 2021-07-31
In China, teriflunomide in July 2018 was NMPA approved for the treatment of relapsing forms of MS, the trade name Obama Czech Republic, has become the first approved oral DMT-listed drugs .
-
CDE expert one-on-one original supplementary package question and answer you are thinking of is here!
Time of Update: 2021-07-31
Q: During the review process of an API (before the on-site assessment), it is found that the original supplier of a certain starting material has stopped production and needs to change the manufacturer.
